当前位置:首页 - 行情中心 - 九安医疗(002432) - 财务分析

九安医疗

(002432)

  

流通市值:309.41亿  总市值:309.82亿
流通股本:4.65亿   总股本:4.66亿

九安医疗(002432)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润3.04亿元,每股收益0.70元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益2182534.81万元,未分配利润2058795.97万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产2990768.72万元,负债808233.92万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入301,482,711.391,365,588,936.681,069,311,569.11765,265,184.21
营业总成本361,006,778.841,634,094,344.461,275,596,464.12897,862,987.49
其他经营收益
营业利润389,807,214.712,535,392,352.31,595,068,871.16981,091,127.85
利润总额385,861,006.422,527,258,849.571,596,307,146.21981,043,992.75
净利润304,457,207.992,269,504,490.991,587,758,433.66920,175,295.83
每股收益
其他综合收益-510,988,207.81-504,390,801.1181,832,104.69361,186,484.93
综合收益总额-206,530,999.821,765,113,689.881,669,590,538.351,281,361,780.76
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计13,381,885,621.4411,935,688,000.1115,222,829,419.915,535,869,391.18
非流动资产:
非流动资产合计16,525,801,611.9417,375,169,000.7713,758,791,392.4113,123,556,839.83
资产总计29,907,687,233.3829,310,857,000.8828,981,620,812.3128,659,426,231.01
流动负债:
流动负债合计4,560,293,157.424,509,674,513.263,189,095,554.214,525,978,981.19
非流动负债:
非流动负债合计3,522,046,024.782,766,268,915.783,371,509,709.022,093,639,356.25
负债合计8,082,339,182.27,275,943,429.046,560,605,263.236,619,618,337.44
所有者权益(或股东权益):
归属于母公司股东权益合计21,617,476,644.0321,832,159,034.2522,189,231,323.921,774,412,884.07
股东权益合计21,825,348,051.1822,034,913,571.8422,421,015,549.0822,039,807,893.57
负债和股东权益合计29,907,687,233.3829,310,857,000.8828,981,620,812.3128,659,426,231.01
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计320,245,779.591,618,362,419.421,222,138,963.14888,299,929.66
经营活动现金流出小计412,721,047.321,785,165,636.321,256,207,811.73872,041,227.11
经营活动产生的现金流量净额-92,475,267.73-166,803,216.9-34,068,848.5916,258,702.55
投资活动产生的现金流量:
投资活动现金流入小计7,615,562,869.4711,305,763,442.529,275,809,471.953,645,342,159.43
投资活动现金流出小计8,644,560,063.5812,034,209,566.989,939,251,224.424,810,337,593.46
投资活动产生的现金流量净额-1,028,997,194.11-728,446,124.46-663,441,752.47-1,164,995,434.03
筹资活动产生的现金流量:
筹资活动现金流入小计4,416,408,569.369,132,931,270.627,106,440,878.063,811,604,717.44
筹资活动现金流出小计3,527,873,274.728,609,237,821.156,227,292,227.493,229,740,383.68
筹资活动产生的现金流量净额888,535,294.64523,693,449.47879,148,650.57581,864,333.76
汇率变动对现金及现金等价物的影响-48,011,943.18-71,077,725.24-36,864,029.35-11,002,856.19
现金及现金等价物净增加额-280,949,110.38-442,633,617.13144,774,020.16-577,875,253.91
期末现金及现金等价物余额2,112,046,123.012,392,995,233.392,980,402,870.682,257,753,596.61
补充资料:
现金及现金等价物的净增加额--442,633,617.13--577,875,253.91
最新报告期:2026-05-27
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
华创证券郑辰,张良龙,李婵娟5.636.627.822026-05-27
TOP↑